Aspirin for Heart Disease

(ASCAD-P Trial)

This trial explores whether taking a low-dose aspirin daily can benefit people with early signs of heart disease, even without symptoms. Researchers aim to determine if prescribing aspirin makes a difference compared to not taking it. Participants will be divided into two groups: one will take aspirin daily, and the other will not. Individuals with early signs of coronary artery disease, such as some calcium build-up in heart arteries, but without major heart issues like a heart attack or stroke, might be a good fit. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to potentially groundbreaking treatment advancements.

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently prescribed aspirin or other antithrombotic medications.

Research has shown that low-dose aspirin can lower the risk of heart attacks and strokes, but it may also increase bleeding risk. One study found that people who took aspirin experienced fewer heart attacks but faced a higher chance of serious bleeding. Another study showed similar results, with aspirin reducing heart problems but increasing bleeding events. Although low-dose aspirin is often used and generally safe, these findings emphasize the need to balance its benefits with the risk of bleeding when considering it as a treatment.¹²³⁴⁵

Researchers are excited about using low-dose aspirin for heart disease because it offers a simple yet effective way to help prevent heart attacks. Unlike some other treatments that may involve complex medications or procedures, aspirin works by thinning the blood, which reduces the risk of blood clots forming in the arteries. This makes it an accessible option for many people, as it is both cost-effective and easy to administer with just one daily pill. Additionally, aspirin has been widely studied and has a long history of use, which gives researchers confidence in its safety profile.

Research has shown that low-dose aspirin can lower the risk of serious heart problems, such as heart attacks and strokes. Studies have found that people with a history of heart disease who take aspirin experience fewer of these events. One study found that individuals with Type 2 diabetes who took low-dose aspirin were less likely to have a heart attack than those who did not. However, aspirin can also increase the risk of serious bleeding, which is important to consider. In this trial, participants will receive either a low-dose aspirin prescription or no prescription to evaluate its effects. Overall, healthcare providers often recommend aspirin for people at higher risk of heart disease to help prevent further issues.¹²³⁴⁶